Brambles (ASX:BXB) cuts FY26 profit guidance on a US$60m US repair capacity hit, but announces a new US$400m on-market buyback.
Charlie Youlden
Pure Resources (ASX:PR1) appoints sitting AML3D CEO Sean Ebert as Board Adviser, signalling a defence materials re-rate path modelled on AML3D’s playbook.
Most people who get into trading start the same way. They watch a few YouTube videos, open a demo account, feel confident for about two weeks, and then slowly realize the market does not care about their confidence. At that point, two paths open up: keep figuring it out alone, or find someone who has…
Ventia Services Group (ASX:VNT) has renewed its Yarra Valley Water contract for A$405 million over nine years, consolidating four contracts into one.
Osteopore (ASX:OSX) secured Malaysian regulatory access for its orthopaedic portfolio, opening a US$250-300m bone graft market with a halal-friendly biomaterials angle.
Civmec (ASX:CVL) lifts its order book 70% to A$1.3bn in Q3 FY26 as defence funding and resources tenders converge.
Alkane Resources (ASX:ALK) delivered a record A$93m quarterly profit on A$274m revenue as its three-mine portfolio and Mandalay merger compounded.
ClearView Wealth (ASX:CVW) and Zurich got the ACCC’s approval to join forces, leaving APRA, the shareholder vote and Court approval as the final hurdles.
AVITA Medical (ASX:AVH) Q1 2026 revenue rose 10% sequentially to US$19.3m but cash fell to US$14.3m as a new CEO and BARDA deal reset the story.
Cerebras Systems (NASDAQ:CBRS) surged on debut after pricing at $185, opening at $350 and landing a major OpenAI AI infrastructure deal.
